FX-322

· Frequency Therapeutics

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for FX-322, covering 2018-04-12 to 2023-04-27. Get the full timeline:

Most recent: Clinical Trial Update: FX-322 in Adults With Stable Sensorineural Hearing Loss [Phase 2]